Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
VonjoPacritinib Citrate
JAK1 / JAK2 InhibitorOral Film-Coated Tablet / Capsule
Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).
View Drug Details & Inquire→
VoranigoVorasidenib Citrate
Targeted Oncology AgentOral Tablet / Capsule
Approved for use in oncology care according to FDA-approved indications.
View Drug Details & Inquire→
Vorasidenib CitrateVorasidenib Citrate
Targeted Oncology AgentOral Tablet / Capsule
Approved for use in oncology care according to FDA-approved indications.
View Drug Details & Inquire→
VoraxazeGlucarpidase
Targeted Oncology AgentOral Tablet / Capsule
Approved for use in oncology care according to FDA-approved indications.
View Drug Details & Inquire→
VorinostatVorinostat
Targeted Oncology AgentOral Tablet / Capsule
Approved for use in oncology care according to FDA-approved indications.
View Drug Details & Inquire→
VotrientPazopanib Hydrochloride
Targeted Oncology AgentOral Tablet / Capsule
Approved for use in oncology care according to FDA-approved indications.
View Drug Details & Inquire→
VyloyZolbetuximab-clzb
Targeted Monoclonal AntibodyIntravenous Solution / Subcutaneous Injection
Targeted treatment of solid tumors and hematologic malignancies.
View Drug Details & Inquire→
VyxeosDaunorubicin Hydrochloride and Cytarabine Liposome
Cytotoxic Antimetabolite Chemotherapeutic AgentLyophilized Powder / Solution for Intravenous Infusion
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
View Drug Details & Inquire→